Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial.
Cannellotto M, Duarte M, Keller G, Larrea R, Cunto E, Chediack V, Mansur M, Brito DM, García E, Di Salvo HE, Verdini F, Domínguez C, Jorda-Vargas L, Roberti J, Di Girolamo G, Estrada E.
Cannellotto M, et al. Among authors: di salvo he.
Emerg Med J. 2022 Feb;39(2):88-93. doi: 10.1136/emermed-2021-211253. Epub 2021 Dec 14.
Emerg Med J. 2022.
PMID: 34907003
Free PMC article.
Clinical Trial.